Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Andrographolide Reverses Doxorubicin Resistance in Human Breast Cancer Stem Cells by Regulating Apoptotic Gene Expressions

The Indonesian Biomedical Journal · Vol. 15 No. 5 (2023) · hlm. 288–296

DOI
10.18585/inabj.v15i5.2596
ISSN
2085-3297, 2355-9179
Terbit
2023-10-18
Penerbit
Secretariat of The Indonesian Biomedical Journal
Bahasa
en
Lisensi
creativecommons.org/licenses/by-nc/4.0/

Abstrak

BACKGROUND: Breast cancer stem cells (BCSCs) have been identified as playing a crucial role in therapeutic resistance. This resistance can be attributed to the anti-apoptotic protein survivin and the antioxidant MnSOD high expression. To overcome the resistance to doxorubicin (DOX), this study proposed the utilization of andrographolide (ANDRO), the primary bioactive compound in Andrographis paniculata leaves. The objective was to examine the role of andrographolide in regulating survivin, caspase-9, and caspase-3 gene expressions to reverse doxorubicin resistance in human BCSCs.METHODS: BCSCs were exposed to 0.1 µM DOX every two days or 50 µM rotenone (ROT) for 6 hours, subsequently supplemented with 0.3 mM ANDRO. Superoxide and peroxide levels were measured using DHE and DCFH-DA assay. The MnSOD, survivin, caspase-9, and caspase-3 mRNA expression levels were analyzed using qRT-PCR. Protein expressions were evaluated using Western blotting assay. MnSOD activity was determined using xanthine oxidase inhibition assay. The apoptotic cells were determined using Annexin-V/PI staining.RESULTS: This study indicated that the cytotoxic mechanisms of DOX, similar to ROT, in BCSCs were attributed to oxidative stress, as evidenced by an elevation in superoxide rather than peroxide levels, accompanied by a decrease in MnSOD activity. This study also highlighted that ANDRO reversed DOX resistance in BCSCs subjected to repeated DOX treatment by downregulating survivin and upregulating caspase-9 and caspase-3 mRNA expressions, thereby activating the intrinsic apoptotic pathway.CONCLUSION: This study provides insights into the role of ANDRO in modulating the expression of apoptotic genes, such as survivin, caspase-9, and caspase-3, to overcome DOX resistance in BCSCs.KEYWORDS: breast cancer, breast cancer stem cell, andrographolide, doxorubicin, oxidative stress, apoptosis

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 147 tautan kepenulisan bersama · 63 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • University of Bengkulu
  • National Research and Innovation Agency
  • University of Liverpool
  • University of Regensburg
  • Atma Jaya Catholic University of Indonesia
  • State University of Jakarta
  • Organisasi lain
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Mohamad SadikinUniversity of Indonesia5
Rini PuspitaningrumState University of Jakarta3
RONDANG ROEMIATI SOEGIANTOUniversitas Kristen Indonesia3
Muhaimin MuhaiminUniversitas Jambi2
Andita Fitri Mutiara RizkiNational Research and Innovation Agency2
Wihda Aisarul AzmiNational Research and Innovation Agency2
I Made ArtikaIPB University2
Josephine Elizabeth SiregarNational Research and Innovation Agency2
Febriana Catur IswantiUniversity of Indonesia2
DARYL ROBERT WILLIAMSUniversity of Liverpool1
Andrew R. CossinsUniversity of Liverpool1
Sri HandayaniState University of Semarang1
Iman SantosoUniversity of Indonesia1
Hans‐Joachim FreislebenUniversity of Indonesia1
Harald HuberUniversity of Regensburg1
AndiUniversity of Indonesia1
Fery ArdiansyahUniversity of Indonesia1
Cenmi MulyantoUniversity of Indonesia1
Zessinda LuthfaUniversity of Indonesia1
Rosari SalehUniversity of Indonesia1
Seruni K.U. FreislebenUniversity of Indonesia1
Michael ThommUniversity of Regensburg1
Maria Dara Novi HandayaniAtma Jaya Catholic University of Indonesia1
Parwati Abadi SoekarnoAtma Jaya Catholic University of Indonesia1
Mahdaleny MahdalenyUniversity of Indonesia1
Noorwati SutandyoDharmais Cancer Hospital1
Mardhatillah SariyantiUniversity of Bengkulu1
Tiara Ayoe AnditaUniversity of Bengkulu1
Noor Diah ErlinawatiUniversity of Bengkulu1
Ahmad Azmi NasutionUniversity of Bengkulu1
Kartika SariUniversity of Bengkulu1
Nikki Aldi MassardiUniversity of Bengkulu1
Sylvia Rianissa PutriUniversity of Bengkulu1
Purnamawati PurnamawatiUniversity of Indonesia1
Alice TamaraUniversity of Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764892910, pertama di-harvest 19 Nov 2026, terakhir terlihat 19 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Andrographolide Reverses Doxorubicin Resistance in Human Breast Cancer Stem Cells by Regulating Apoptotic Gene Expressions</dc:title><dc:creator>Septelia Inawati Wanandi</dc:creator><dc:creator>Resda Akhra Syahrani</dc:creator><dc:creator>Ayu Suraduhita</dc:creator><dc:creator>Elvira Yunita</dc:creator><dc:creator>Melva Louisa</dc:creator><dc:subject>andrographolide</dc:subject><dc:subject>doxorubicin resistance</dc:subject><dc:subject>breast cancer stem cells</dc:subject><dc:subject>survivin</dc:subject><dc:subject>caspase-9</dc:subject><dc:subject>caspase-3</dc:subject><dc:subject>oxidative stress</dc:subject><dc:subject>manganese superoxide dismutase</dc:subject><dc:subject>apoptosis</dc:subject><dc:subject>Andrographis paniculata</dc:subject><dc:subject>mitochondrial apoptosis</dc:subject><dc:subject>rotenone</dc:subject><dc:description xml:lang="en">BACKGROUND: Breast cancer stem cells (BCSCs) have been identified as playing a crucial role in therapeutic resistance. This resistance can be attributed to the anti-apoptotic protein survivin and the antioxidant MnSOD high expression. To overcome the resistance to doxorubicin (DOX), this study proposed the utilization of andrographolide (ANDRO), the primary bioactive compound in Andrographis paniculata leaves. The objective was to examine the role of andrographolide in regulating survivin, caspase-9, and caspase-3 gene expressions to reverse doxorubicin resistance in human BCSCs.METHODS: BCSCs were exposed to 0.1 µM DOX every two days or 50 µM rotenone (ROT) for 6 hours, subsequently supplemented with 0.3 mM ANDRO. Superoxide and peroxide levels were measured using DHE and DCFH-DA assay. The MnSOD, survivin, caspase-9, and caspase-3 mRNA expression levels were analyzed using qRT-PCR. Protein expressions were evaluated using Western blotting assay. MnSOD activity was determined using xanthine oxidase inhibition assay. The apoptotic cells were determined using Annexin-V/PI staining.RESULTS: This study indicated that the cytotoxic mechanisms of DOX, similar to ROT, in BCSCs were attributed to oxidative stress, as evidenced by an elevation in superoxide rather than peroxide levels, accompanied by a decrease in MnSOD activity. This study also highlighted that ANDRO reversed DOX resistance in BCSCs subjected to repeated DOX treatment by downregulating survivin and upregulating caspase-9 and caspase-3 mRNA expressions, thereby activating the intrinsic apoptotic pathway.CONCLUSION: This study provides insights into the role of ANDRO in modulating the expression of apoptotic genes, such as survivin, caspase-9, and caspase-3, to overcome DOX resistance in BCSCs.KEYWORDS: breast cancer, breast cancer stem cell, andrographolide, doxorubicin, oxidative stress, apoptosis</dc:description><dc:publisher>Secretariat of The Indonesian Biomedical Journal</dc:publisher><dc:date>2023-10-18</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.18585/inabj.v15i5.2596</dc:identifier><dc:identifier>10.18585/inabj.v15i5.2596</dc:identifier><dc:source>The Indonesian Biomedical Journal; Vol 15 No 5 (2023); 288-296</dc:source><dc:source>2085-3297</dc:source><dc:source>2355-9179</dc:source><dc:language>en</dc:language><dc:relation>https://inabj.org/index.php/ibj/article/download/2596/663</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc/4.0/</dc:rights></oai_dc:dc>